
A technology platform from Danish company ExpreS2ion Biotechnologies is going to be used at another British research institute. The biotech company has announced the signing of a licensing agreement with the London Research Institute.
It is less than a year since the Danes struck a similar deal with Oxford University.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app